Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF. [electronic resource]
Producer: 20100527Description: 3606-17 p. digitalISSN:- 1538-7445
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Cell Line, Tumor
- Curcumin -- administration & dosage
- DNA, Complementary -- genetics
- DNA, Neoplasm -- genetics
- Deoxycytidine -- administration & dosage
- Dinoprostone -- antagonists & inhibitors
- Drug Synergism
- Gene Expression Regulation, Neoplastic -- genetics
- Gene Silencing
- Humans
- MicroRNAs -- biosynthesis
- NF-kappa B -- antagonists & inhibitors
- Oligonucleotides, Antisense -- genetics
- PTEN Phosphohydrolase -- genetics
- Pancreatic Neoplasms -- drug therapy
- Transfection
- Triterpenes -- administration & dosage
- Vascular Endothelial Growth Factor A -- antagonists & inhibitors
- Gemcitabine
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Retracted Publication
There are no comments on this title.
Log in to your account to post a comment.